# Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors

> **NCT04787003** · PHASE1 · UNKNOWN · sponsor: **North China Petroleum Bureau General Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** oncolytic virus (OVV-01) injection

## Key facts

- **NCT ID:** NCT04787003
- **Lead sponsor:** North China Petroleum Bureau General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-16
- **Primary completion:** 2023-10-01
- **Final completion:** 2024-02-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04787003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04787003, "Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04787003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*